Target intelligence / Profile preview

Neisseria meningitidis serogroup W135 (N. meningitidis W135)

Target
N. meningitidis W135
Molecular classification
Other (Bacterial serogroup), No receptor, enzyme, transporter, or similar target classification applies.
01

Overview

Neisseria meningitidis serogroup W135 is a subgroup of *Neisseria meningitidis* characterized by its specific capsular polysaccharide. It is a Gram-negative, encapsulated diplococcus found in the family Neisseriaceae. W135 is distinguished by molecular typing and is part of the clonal complex ST-11, responsible for significant global outbreaks, including a well-known epidemic during the Hajj in 2000[2][5][8]. This serogroup is a leading cause of invasive meningococcal disease, presenting primarily as meningitis and sepsis, and is associated with high mortality and morbidity worldwide[3][7][9]. Surveillance and vaccination programs are critical for management due to its rapid disease progression and potential for antibiotic resistance[1][5][9].

Other names
Meningococcus W135MenW135N. meningitidis W135Meningococcal group WEpidemic clone ST-11 W135
02

Mechanism of action

Bactericidal inhibition of cell wall synthesis (β-lactams: penicillins, cephalosporins) Blockage of nucleic acid synthesis (rifampin, ciprofloxacin) Immunization-induced antibody production (vaccine)

03

Biological functions

Immune evasion (mediated by polysaccharide capsule, not the group itself)Infection (disease causation)
04

Disease associations

Infection (meningococcal disease: invasive meningitis, septicemia)
05

Safety considerations

Rapid progression of disease (meningococcemia, fulminant meningitis)Antibiotic resistance (intermediate or resistant strains to penicillin, ciprofloxacin noted)Outbreaks and international spread (notably after 2000 Hajj)Vaccination coverage gaps (not all regions immunized against W135)Severe morbidity and mortality
06

Interacting drugs

Penicillins (e.g., penicillin, ampicillin)

4 more in the full profile.

07

Biomarkers

Polysaccharide capsule typing (W135 antigen detection)MLST clonal complex ST-11PorA, PorB, 16S rRNA sequencing

Beyond the preview

Go deeper on Neisseria meningitidis serogroup W135 (N. meningitidis W135).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup W135 (N. meningitidis W135).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call